Veru partners with Novo Nordisk for obesity drug combination study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Veru partners with Novo Nordisk for obesity drug combination study
NOVO-NORDISK A/S (NYSE: NVO) Delayed: 47.42 +1.54 (3.36%)
Previous Close $45.88    52 Week High $59.00 
Open $46.80    52 Week Low $32.80 
Day High $47.43    P/E N/A 
Day Low $46.44    EPS $0.00 
Volume 20,222,572       

(NASDAQ: VERU) Delayed: 3.04 +0.08 (2.70%)
Previous Close $2.96    52 Week High $ 
Open $2.91    52 Week Low $ 
Day High $3.07    P/E N/A 
Day Low $2.91    EPS $ 
Volume 344,774